Not applicableLooking for participantsNCT03308474What this trial is testingMyeloma Registry Platform (MYRIAM)Who this might be right forMultiple Myeloma iOMEDICO AG 2,200
Testing effectiveness (Phase 2)Study completedNCT00965224What this trial is testingEfficacy of Dendritic Cell Therapy for Myeloid Leukemia and MyelomaWho this might be right forAcute Myeloid LeukemiaChronic Myeloid LeukemiaMultiple Myeloma Zwi Berneman 38
Early research (Phase 1)Study completedNCT00552396What this trial is testingAn Open-label, Dose-escalation Safety and Tolerability Trial Assessing Anti-KIR (1-7F9) in Subjects With Multiple MyelomaWho this might be right forMultiple Myeloma Innate Pharma 32
Very early researchLooking for participantsNCT07771803What this trial is testingA Pilot Study of Soursop Tea in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML) or Multiple Myeloma (MM)Who this might be right forAML (Acute Myeloid Leukemia)Multiple Myeloma Refractory Roger Strair 20
Early research (Phase 1)Ended earlyNCT00469820What this trial is testingVaccine Therapy With or Without Donor Lymphocyte Infusion in Treating Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Multiple Myeloma Undergoing Donor Stem Cell TransplantWho this might be right forLeukemiaMultiple Myeloma and Plasma Cell Neoplasm Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 1
Early research (Phase 1)UnknownNCT00891280What this trial is testingDose-escalation Study of Oral CX-4945Who this might be right forAdvanced Solid TumorsBreast CancerInflammatory Breast Cancer+2 more Cylene Pharmaceuticals 55
Early research (Phase 1)Looking for participantsNCT07541391What this trial is testingAutologous Chimeric Antigen Receptor (CAR) T-cells Targeting the Kappa Myeloma Antigen (KMA) in Kappa Restricted Multiple Myeloma Patients With Relapsed/Refractory DiseaseWho this might be right forRelapsed/Refractory Multiple Myeloma Peter MacCallum Cancer Centre, Australia 12
Large-scale testing (Phase 3)Active Not RecruitingNCT04162210What this trial is testingStudy of Single Agent Belantamab Mafodotin Versus Pomalidomide Plus Low-dose Dexamethasone (Pom/Dex) in Participants With Relapsed/Refractory Multiple Myeloma (RRMM)Who this might be right forMultiple Myeloma GlaxoSmithKline 325
Not applicableUnknownNCT02387879What this trial is testingA Non-interventional,Observational Post Authorization Study of Patients With Multiple Myeloma Treated With Lenalidomide TRWho this might be right forMultiple Myeloma Celgene 500
Testing effectiveness (Phase 2)Active Not RecruitingNCT03346135What this trial is testingDaratumumab After Stem Cell Transplant in Treating Patients With Multiple MyelomaWho this might be right forPlasma Cell MyelomaSecondary Amyloidosis City of Hope Medical Center 31
Testing effectiveness (Phase 2)Study completedNCT02362035What this trial is testingACP-196 (Acalabrutinib) in Combination With Pembrolizumab, for Treatment of Hematologic MalignanciesWho this might be right forFollicular Lymphoma (FL)CLLSmall Lymphocytic Lymphoma (SLL)+10 more Acerta Pharma BV 161
Testing effectiveness (Phase 2)Ended earlyNCT00431340What this trial is testingA Phase II Study of Belinostat in Combination With Bortezomib in Patients With Relapsed, Refractory Multiple MyelomaWho this might be right forMultiple Myeloma Valerio Therapeutics 4
Early research (Phase 1)Study completedNCT01660750What this trial is testingA Safety Study of Carfilzomib, Cyclophosphamide & Dexamethasone Prior to ASCT in Patients With Newly Diagnosed MyelomaWho this might be right forMultiple Myeloma Criterium, Inc. 29
Testing effectiveness (Phase 2)Study completedNCT00216697What this trial is testingAn Extension Study to Provide Bortezomib to Patients With Relapsed or Refractory Multiple Myeloma Who Previously Participated in a Bortezomib Phase I/II Study and Who May Benefit From Re-Treatment With or Continuation of Bortezomib TherapyWho this might be right forMultiple Myeloma Janssen Pharmaceutical K.K. 13
Testing effectiveness (Phase 2)Active Not RecruitingNCT01297764What this trial is testingCarfilzomib, Lenalidomide, Vorinostat, and Dexamethasone in Relapsed and/or Refractory Multiple MyelomaWho this might be right forMultiple Myeloma Hackensack Meridian Health 17
Early research (Phase 1)Looking for participantsNCT05650632What this trial is testingAssess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple MyelomaWho this might be right forMultiple Myeloma AbbVie 210
Early research (Phase 1)Ended earlyNCT00934232What this trial is testingBusulfan in Multiple MyelomaWho this might be right forMultiple Myeloma Guido Tricot 13
Testing effectiveness (Phase 2)Study completedNCT01408563What this trial is testingReduced Intensity Double Umbilical Cord Blood TransplantationWho this might be right forNon-Hodgkin's LymphomaHodgkin's LymphomaMultiple Myeloma+2 more Massachusetts General Hospital 33
Not applicableLooking for participantsNCT07111884What this trial is testingGMMG Multiple Myeloma RegistryWho this might be right forMultiple Myeloma Prof. Dr. Hartmut Goldschmidt 999
Testing effectiveness (Phase 2)Study completedNCT01183949What this trial is testingEffect of AT7519M Alone and AT7519M Plus Bortezomib in Patients With Previously Treated Multiple MyelomaWho this might be right forMultiple Myeloma Astex Pharmaceuticals, Inc. 18